Alterations in T cells of cancer-bearers: Whence specificity?

被引:51
作者
Levey, DL
Srivastava, PK
机构
来源
IMMUNOLOGY TODAY | 1996年 / 17卷 / 08期
关键词
D O I
10.1016/0167-5699(96)10013-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cells of tumor-bearing mice and cancer patients have been reported to have altered signal-transduction machinery. These alterations have been implicated in immunological suppression. Here, Daniel Levey and Pramod Srivastava critically examine the evidence for these alterations in the context of the tumor specificity of immunological unresponsiveness in tumor-bearing hosts.
引用
收藏
页码:365 / 368
页数:4
相关论文
共 39 条
[11]  
FRANCO JL, 1995, CANCER RES, V55, P3840
[12]   STRUCTURAL MUTATIONS OF THE T-CELL RECEPTOR ZETA-CHAIN AND ITS ROLE IN T-CELL ACTIVATION [J].
FRANK, SJ ;
NIKLINSKA, BB ;
ORLOFF, DG ;
MERCEP, M ;
ASHWELL, JD ;
KLAUSNER, RD .
SCIENCE, 1990, 249 (4965) :174-177
[13]   ANERGIC T-LYMPHOCYTE CLONES HAVE ALTERED INOSITOL PHOSPHATE, CALCIUM, AND TYROSINE KINASE SIGNALING PATHWAYS [J].
GAJEWSKI, TF ;
QIAN, DP ;
FIELDS, P ;
FITCH, FW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (01) :38-42
[14]  
GHOSH P, 1994, CANCER RES, V54, P2969
[15]  
GRILLI M, 1993, INT REV CYTOL, V143, P1
[16]   THE CYTOPLASMIC TAIL OF THE T-CELL RECEPTOR ZETA-CHAIN IS DISPENSABLE FOR ANTIGEN-MEDIATED T-CELL ACTIVATION [J].
HERMANS, MHA ;
MALISSEN, B .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (09) :2257-2262
[17]  
KOPP EB, 1995, ADV IMMUNOL, V58, P1, DOI 10.1016/S0065-2776(08)60618-5
[18]   T-CELLS FROM LATE TUMOR-BEARING MICE EXPRESS NORMAL LEVELS OF P56(LCK), P59(FYN), ZAP-70, AND CD3-ZETA DESPITE SUPPRESSED CYTOLYTIC ACTIVITY [J].
LEVEY, DL ;
SRIVASTAVA, PK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (04) :1029-1036
[19]  
LI XL, 1994, CANCER RES, V54, P5424
[20]  
MARTH JD, 1989, J IMMUNOL, V142, P2430